Houston John G
- SEC CIK
- 0001753537
In the past year, 1 open-market sale filing worth $466.2K and no purchases.
Current role at each company
- NXTC NextCure, Inc.Directoras of Jun 22, 2026
- ARVN Arvinas, Inc.Directoras of Mar 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $466.2K
- 1 filing
- Net
- −$466.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Houston John G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARVN Arvinas, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 (view filing) | Feb 27 | 3 days | Houston John GDirector | SSale | −35.3K | $13.21 | −$466.2K | −3.0%1.12M after | 3 lots |
| Feb 25, 2025 (view filing) | Feb 24 | 1 day | Houston John GPresident and CEO | SSale | −31.3K | $16.72 | −$523.9K | −2.6%1.16M after | 2 lots |
| Feb 27, 2024 (view filing) | Feb 23 | 4 days | Houston John GPresident and CEO | SSale | −5.20K | $47.05 | −$244.5K | −0.5%1.04M after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Houston John GPresident and CEO | SSale | −5.88K | $29.53 | −$173.6K | −0.6%917.4K after | |
| Mar 4, 2022 (view filing) | Mar 4 | Same day | Houston John GPresident and CEO | SSale | −6.02K | $63.94 | −$385.2K | −0.7%843.8K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Houston John GPresident and CEO | SSale | −40.0K | $88.14 | −$3.53M | −4.6%832.3K after | 3 lots |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Houston John GPresident and CEO | SSale | −45.9K | $97.83 | −$4.49M | −5.3%827.6K after | 5 lots |